These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 19034308)

  • 1. Dietary alkalinization and darusentan for prevention of decline in glomerular filtration rate in rats fed a casein diet.
    Bakker SJ; Gans RO; Navis G
    Kidney Int; 2008 Dec; 74(12):1625-6; author reply 1626-7. PubMed ID: 19034308
    [No Abstract]   [Full Text] [Related]  

  • 2. Acid retention during kidney failure induces endothelin and aldosterone production which lead to progressive GFR decline, a situation ameliorated by alkali diet.
    Wesson DE; Simoni J
    Kidney Int; 2010 Dec; 78(11):1128-35. PubMed ID: 20861823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary protein causes a decline in the glomerular filtration rate of the remnant kidney mediated by metabolic acidosis and endothelin receptors.
    Phisitkul S; Hacker C; Simoni J; Tran RM; Wesson DE
    Kidney Int; 2008 Jan; 73(2):192-9. PubMed ID: 17978813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary protein induces endothelin-mediated kidney injury through enhanced intrinsic acid production.
    Wesson DE; Nathan T; Rose T; Simoni J; Tran RM
    Kidney Int; 2007 Feb; 71(3):210-7. PubMed ID: 17164833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of darusentan: a novel endothelin receptor antagonist.
    Epstein BJ
    Ann Pharmacother; 2008 Jul; 42(7):1060-9. PubMed ID: 18523233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Darusentan: a new perspective for treatment of resistant hypertension?
    Enseleit F; Lüscher TF; Ruschitzka F
    Expert Opin Investig Drugs; 2008 Aug; 17(8):1255-63. PubMed ID: 18616421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased tissue acid mediates a progressive decline in the glomerular filtration rate of animals with reduced nephron mass.
    Wesson DE; Simoni J
    Kidney Int; 2009 May; 75(9):929-35. PubMed ID: 19190678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of medial elastocalcinosis in rat aorta: a new vascular function for carbonic anhydrase.
    Essalihi R; Dao HH; Gilbert LA; Bouvet C; Semerjian Y; McKee MD; Moreau P
    Circulation; 2005 Sep; 112(11):1628-35. PubMed ID: 16144999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An endothelin antagonist for resistant hypertension.
    Dhaun N; Goddard J; Webb DJ
    Lancet; 2010 Feb; 375(9715):635; author reply 636-7. PubMed ID: 20171390
    [No Abstract]   [Full Text] [Related]  

  • 10. An endothelin antagonist for resistant hypertension.
    O'Brien E
    Lancet; 2010 Feb; 375(9715):636; author reply 636-7. PubMed ID: 20171394
    [No Abstract]   [Full Text] [Related]  

  • 11. An endothelin antagonist for resistant hypertension.
    Bharti B; Bharti S
    Lancet; 2010 Feb; 375(9715):635; author reply 636-7. PubMed ID: 20171391
    [No Abstract]   [Full Text] [Related]  

  • 12. An endothelin antagonist for resistant hypertension.
    Naunton M
    Lancet; 2010 Feb; 375(9715):636; author reply 636-7. PubMed ID: 20171393
    [No Abstract]   [Full Text] [Related]  

  • 13. Up-regulated inflammatory factors endothelin, NFkappaB, TNFalpha and iNOS involved in exaggerated cardiac arrhythmias in l-thyroxine-induced cardiomyopathy are suppressed by darusentan in rats.
    Xia HJ; Dai DZ; Dai Y
    Life Sci; 2006 Oct; 79(19):1812-9. PubMed ID: 16822527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition.
    Ortmann J; Amann K; Brandes RP; Kretzler M; Münter K; Parekh N; Traupe T; Lange M; Lattmann T; Barton M
    Hypertension; 2004 Dec; 44(6):974-81. PubMed ID: 15545511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-A receptor antagonist reduces microcirculatory disturbances and transplant dysfunction after partial liver transplantation.
    Palmes D; Budny TB; Stratmann U; Herbst H; Spiegel HU
    Liver Transpl; 2003 Sep; 9(9):929-39. PubMed ID: 12942454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-pharmacodynamic assessment of the interrelationships between tesaglitazar exposure and renal function in patients with type 2 diabetes mellitus.
    Hamrén B; Ohman KP; Svensson MK; Karlsson MO
    J Clin Pharmacol; 2012 Sep; 52(9):1317-27. PubMed ID: 22045829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin receptor A blockade reduces proteinuria and vascular hypertrophy in spontaneously hypertensive rats on high-salt diet in a blood-pressure-independent manner.
    Trenkner J; Priem F; Bauer C; Neumayer HH; Raschak M; Hocher B
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():385S-388S. PubMed ID: 12193128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of pirprofen on renal function in man.
    Kalos A; Lazaridis I; Malamas N; Kasfiki A; Drivas G; Germenis A; Grammenon S
    Singapore Med J; 1987 Apr; 28(2):172-5. PubMed ID: 3629273
    [No Abstract]   [Full Text] [Related]  

  • 19. Endothelin receptor blockade in severe acute pancreatitis leads to systemic enhancement of microcirculation, stabilization of capillary permeability, and improved survival rates.
    Foitzik T; Eibl G; Hotz HG; Faulhaber J; Kirchengast M; Buhr HJ
    Surgery; 2000 Sep; 128(3):399-407. PubMed ID: 10965310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate.
    Goraya N; Simoni J; Jo CH; Wesson DE
    Kidney Int; 2014 Nov; 86(5):1031-8. PubMed ID: 24694986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.